Live Analyst Rating Changes 1515 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Daniel Arias
STIF
Daniel Arias
Stifel Nicolaus
Wall Street Analyst
★★★☆☆
#1648
on 13Foresight · ranked by our own returns
48%
Success Rate
+0.2%
Average Return
11 of 23 calls profitable · -2.1% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 48% of Daniel Arias's ratings turned a profit when each position was held for 1 year — averaging +0.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

64 Buy 37 Hold 0 Sell
Daniel's Stock Coverage 24 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
QGEN
Qiagen
 Jun 16, 2026 HOLD Buy
+14.1% avg upside
23 analysts
$36.00
2.62% Downside
 ·
ALMR
Alamar Biosciences, Inc.
 Jun 09, 2026 BUY Strong Buy
+39.4% avg upside
5 analysts
$28.00
27.45% Upside
 ·
TEM
Tempus AI, Inc. Class A
 Jun 01, 2026 HOLD Strong Buy
+33.8% avg upside
19 analysts
$60.00
17.93% Upside
 -4.2%
GH
Guardant Health
 May 28, 2026 BUY Strong Buy
-5.8% avg upside
30 analysts
$130.00
1.25% Downside
 -2.5%
A
Agilent
 May 28, 2026 BUY Strong Buy
+3.9% avg upside
32 analysts
$170.00
33.85% Upside
 -2.0%
TMO
Thermo Fisher
 May 21, 2026 BUY Strong Buy
+26.9% avg upside
38 analysts
$600.00
29.20% Upside
 +5.2%
MTD
Mettler-Toledo
 May 18, 2026 BUY Buy
+2.7% avg upside
18 analysts
$1400.00
22.32% Upside
 +7.4%
WAT
Waters
 May 18, 2026 HOLD Strong Buy
+3.5% avg upside
30 analysts
$380.00
6.85% Upside
 +7.7%
RPID
Rapid Micro Biosystems
 May 14, 2026 BUY Strong Buy
+411.7% avg upside
6 analysts
$8.00
367.93% Upside
 -14.2%
MXCT
MaxCyte
 May 13, 2026 BUY Buy
+230.6% avg upside
5 analysts
$4.00
230.63% Upside
 +2.0%
MRVI
Maravai Lifesciences Holdings
 May 11, 2026 BUY Strong Buy
+175.0% avg upside
17 analysts
$6.00
15.34% Upside
 -12.4%
BRKR
Bruker
 May 08, 2026 HOLD Buy
-7.0% avg upside
22 analysts
$45.00
21.44% Downside
 +23.9%
BLLN
BillionToOne, Inc. Class A
 May 07, 2026 BUY Strong Buy
+16.4% avg upside
8 analysts
$145.00
37.80% Upside
 +8.8%
MASS
908 Devices
 May 07, 2026 BUY Strong Buy
+26.5% avg upside
4 analysts
$10.00
13.09% Upside
 -14.6%
TECH
Bio-Techne
 May 07, 2026 HOLD Strong Buy
+38.6% avg upside
21 analysts
$50.00
13.65% Downside
 +10.3%
RGEN
Repligen
 May 06, 2026 BUY Strong Buy
+28.3% avg upside
25 analysts
$207.00
56.82% Upside
 -2.7%
RVTY
Revvity
 May 06, 2026 HOLD Buy
+5.5% avg upside
23 analysts
$100.00
0.10% Upside
 -1.3%
ILMN
Illumina
 May 01, 2026 BUY Buy
-10.0% avg upside
30 analysts
$155.00
4.24% Downside
 +17.2%
AVTR
Avantor
 Apr 30, 2026 HOLD Buy
+49.6% avg upside
26 analysts
$8.00
16.46% Downside
 +18.9%
DHR
Danaher
 Apr 22, 2026 BUY Strong Buy
+21.8% avg upside
45 analysts
$260.00
46.68% Upside
 -1.5%
TXG
10x Genomics
 Mar 02, 2026 BUY Buy
-26.8% avg upside
18 analysts
$25.00
28.09% Downside
 +37.2%
CDXS
Codexis
 Nov 10, 2025 BUY Strong Buy
+291.5% avg upside
13 analysts
$5.00
94.60% Upside
 +40.6%
ABSI
AbSci
 Jan 22, 2025 HOLD Strong Buy
+37.3% avg upside
18 analysts
 — -21.6%
RNLXY
Renalytix
 Mar 01, 2024 BUY Strong Buy
+800.3% avg upside
5 analysts
$5.00
318.79% Upside
 ·
🔒 19 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Daniel Arias — Frequently Asked Questions
How accurate are Daniel Arias's stock ratings?
Based on the calls 13Foresight could measure, about 48% of Daniel's ratings were profitable over a one-year hold, with an average return of +0.2% per rating, or -2.1% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Daniel ranked on 13Foresight?
Daniel Arias is currently ranked #1648 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Daniel cover?
Daniel most recently has ratings on QGEN, ALMR, TEM, GH, A, TMO, MTD, WAT, RPID, MXCT, MRVI, BRKR and 12 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.